Your session is about to expire
← Back to Search
SUFU Clinical Care Pathway for Overactive Bladder for Overactive Bladder (OAB Telemed Trial)
N/A
Waitlist Available
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Idiopathic overactive bladder diagnosis, both OAB wet and OAB dry
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
OAB Telemed Trial Summary
This trial is testing whether telemedicine (video conferencing) is as effective as in-person visits for treating OAB.
Eligible Conditions
- Overactive Bladder
OAB Telemed Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowOAB Telemed Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Patient Satisfaction
Secondary outcome measures
Accumulated cost of visit to patient (Cost)
Accumulated time of visit for patient (Time)
Incidence of Treatment-emergent adverse events (safety and tolerability)
+2 moreOAB Telemed Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Telemedicine ArmExperimental Treatment2 Interventions
Patients will receive OAB treatment as described in the SUFU OAB clinical care pathway but all visits will be performed via telemedicine
Group II: Traditional In-Person Clinic Visit ArmPlacebo Group1 Intervention
Patients will receive overactive bladder (OAB) treatment as described in the Society for Urodynamics and Female Pelvic Medicine and Urogenital Reconstruction (SUFU) OAB clinical care pathway. These patients will have all visits in-person
Find a Location
Who is running the clinical trial?
University of California, Los AngelesLead Sponsor
1,538 Previous Clinical Trials
10,266,854 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger